QT
OLMA icon

Quantbot Technologies’s Olema Pharmaceuticals OLMA Stock Holding History

Quantbot Technologies’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,046
Closed -$201K – 2034
2025
Q4 		$201K Buy
+8,046
New +$143K 0.01% 1235
2022
Q2 		– Sell
-1,277
Closed -$5K – 2000
2022
Q1 		$5K Buy
1,277
+400
+46% +$2.2K ﹤0.01% 1527
2021
Q4 		$8K Buy
+877
New +$18.2K ﹤0.01% 1340

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Quantbot Technologies's OLMA Position: Q1 2026 in Review

Quantbot Technologies sold out of Olema Pharmaceuticals (OLMA) in Q1 2026, closing a stake of 8,046 shares — an estimated $201K sold.

Quantbot Technologies first reported a position in OLMA in Q4 2021 and held it in 3 quarters. The position peaked at $201K in Q4 2025. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Quantbot Technologies reported no remaining Olema Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Quantbot Technologies sold 8,046 Olema Pharmaceuticals shares in Q1 2026, an estimated $201K.
  • Quantbot Technologies first reported a position in Olema Pharmaceuticals in Q4 2021 and held it in 3 quarters.
  • Quantbot Technologies's Olema Pharmaceuticals position peaked at $201K in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.